Start the conversation
The year is nearly half over, and the mainstream media continues to obsess over a whipsaw stock market that's been cutting highflyers down to size.
The sullen outlook has lots of retail investors dumping tech stocks and running for the "safety" of the sidelines. That's a mistake no one should be making.
But tech stocks - and especially biotech stocks - are poised to do very well in the last half of 2014.